FR2514367A1 - Procede pour la detection de germes pathogenes dans des fluides par filtration sur des immunoadsorbants, et application a la determination de la potabilite d'une eau - Google Patents
Procede pour la detection de germes pathogenes dans des fluides par filtration sur des immunoadsorbants, et application a la determination de la potabilite d'une eau Download PDFInfo
- Publication number
- FR2514367A1 FR2514367A1 FR8118985A FR8118985A FR2514367A1 FR 2514367 A1 FR2514367 A1 FR 2514367A1 FR 8118985 A FR8118985 A FR 8118985A FR 8118985 A FR8118985 A FR 8118985A FR 2514367 A1 FR2514367 A1 FR 2514367A1
- Authority
- FR
- France
- Prior art keywords
- sep
- immunoadsorbent
- germs
- specific
- water
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 230000001717 pathogenic effect Effects 0.000 title claims abstract description 16
- 238000001514 detection method Methods 0.000 title claims abstract description 5
- 244000052616 bacterial pathogen Species 0.000 title claims description 27
- 229920000936 Agarose Polymers 0.000 title description 4
- 239000003651 drinking water Substances 0.000 title description 3
- 235000020188 drinking water Nutrition 0.000 title description 3
- 210000002700 urine Anatomy 0.000 title description 2
- 239000003463 adsorbent Substances 0.000 title 1
- 238000000034 method Methods 0.000 claims abstract description 31
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 26
- 238000001914 filtration Methods 0.000 claims abstract description 15
- 239000012530 fluid Substances 0.000 claims abstract description 14
- 230000008569 process Effects 0.000 claims abstract description 12
- 230000000717 retained effect Effects 0.000 claims abstract description 8
- 239000002245 particle Substances 0.000 claims description 11
- 241000588724 Escherichia coli Species 0.000 claims description 10
- 241000710188 Encephalomyocarditis virus Species 0.000 claims description 9
- 241000700605 Viruses Species 0.000 claims description 9
- 230000003612 virological effect Effects 0.000 claims description 9
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 claims description 7
- 241000607626 Vibrio cholerae Species 0.000 claims description 7
- 229940118696 vibrio cholerae Drugs 0.000 claims description 7
- 238000010168 coupling process Methods 0.000 claims description 6
- 241000894006 Bacteria Species 0.000 claims description 4
- 208000000474 Poliomyelitis Diseases 0.000 claims description 4
- 241000607142 Salmonella Species 0.000 claims description 4
- 230000008878 coupling Effects 0.000 claims description 3
- 238000005859 coupling reaction Methods 0.000 claims description 3
- AZQWKYJCGOJGHM-UHFFFAOYSA-N 1,4-benzoquinone Chemical compound O=C1C=CC(=O)C=C1 AZQWKYJCGOJGHM-UHFFFAOYSA-N 0.000 claims description 2
- 239000013060 biological fluid Substances 0.000 claims description 2
- 239000007822 coupling agent Substances 0.000 claims description 2
- 238000012412 chemical coupling Methods 0.000 claims 1
- 230000035622 drinking Effects 0.000 abstract 1
- 239000000499 gel Substances 0.000 description 16
- 241000283973 Oryctolagus cuniculus Species 0.000 description 7
- 229920001817 Agar Polymers 0.000 description 5
- 239000008272 agar Substances 0.000 description 5
- 238000004458 analytical method Methods 0.000 description 5
- 238000002474 experimental method Methods 0.000 description 5
- 230000002550 fecal effect Effects 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- 238000012512 characterization method Methods 0.000 description 4
- 230000003053 immunization Effects 0.000 description 4
- 229920000642 polymer Polymers 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 210000002966 serum Anatomy 0.000 description 4
- 238000011109 contamination Methods 0.000 description 3
- 238000010790 dilution Methods 0.000 description 3
- 239000012895 dilution Substances 0.000 description 3
- 238000010828 elution Methods 0.000 description 3
- 238000002649 immunization Methods 0.000 description 3
- 239000007928 intraperitoneal injection Substances 0.000 description 3
- 238000002955 isolation Methods 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 244000052769 pathogen Species 0.000 description 3
- 239000008363 phosphate buffer Substances 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 2
- 206010003445 Ascites Diseases 0.000 description 2
- 206010008631 Cholera Diseases 0.000 description 2
- 241000991587 Enterovirus C Species 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 241000699666 Mus <mouse, genus> Species 0.000 description 2
- 241000293869 Salmonella enterica subsp. enterica serovar Typhimurium Species 0.000 description 2
- PXIPVTKHYLBLMZ-UHFFFAOYSA-N Sodium azide Chemical compound [Na+].[N-]=[N+]=[N-] PXIPVTKHYLBLMZ-UHFFFAOYSA-N 0.000 description 2
- 230000004520 agglutination Effects 0.000 description 2
- 230000000890 antigenic effect Effects 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 238000010908 decantation Methods 0.000 description 2
- 238000009792 diffusion process Methods 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 230000003287 optical effect Effects 0.000 description 2
- 239000002504 physiological saline solution Substances 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 241000588722 Escherichia Species 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 239000001888 Peptone Substances 0.000 description 1
- 108010080698 Peptones Proteins 0.000 description 1
- 241000607598 Vibrio Species 0.000 description 1
- 206010047400 Vibrio infections Diseases 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 239000011543 agarose gel Substances 0.000 description 1
- 230000004523 agglutinating effect Effects 0.000 description 1
- 238000012870 ammonium sulfate precipitation Methods 0.000 description 1
- 230000000721 bacterilogical effect Effects 0.000 description 1
- 239000011324 bead Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 239000007975 buffered saline Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000005202 decontamination Methods 0.000 description 1
- 230000003588 decontaminative effect Effects 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000003480 eluent Substances 0.000 description 1
- 238000010166 immunofluorescence Methods 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 238000005374 membrane filtration Methods 0.000 description 1
- MYWUZJCMWCOHBA-VIFPVBQESA-N methamphetamine Chemical compound CN[C@@H](C)CC1=CC=CC=C1 MYWUZJCMWCOHBA-VIFPVBQESA-N 0.000 description 1
- 244000000010 microbial pathogen Species 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 235000019319 peptone Nutrition 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 238000004445 quantitative analysis Methods 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000000405 serological effect Effects 0.000 description 1
- 230000007480 spreading Effects 0.000 description 1
- 238000003892 spreading Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000002604 ultrasonography Methods 0.000 description 1
- 230000002850 vibriocidal effect Effects 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 239000003643 water by type Substances 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/544—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being organic
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/544—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being organic
- G01N33/545—Synthetic resin
Landscapes
- Health & Medical Sciences (AREA)
- Immunology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR8118985A FR2514367A1 (fr) | 1981-10-08 | 1981-10-08 | Procede pour la detection de germes pathogenes dans des fluides par filtration sur des immunoadsorbants, et application a la determination de la potabilite d'une eau |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR8118985A FR2514367A1 (fr) | 1981-10-08 | 1981-10-08 | Procede pour la detection de germes pathogenes dans des fluides par filtration sur des immunoadsorbants, et application a la determination de la potabilite d'une eau |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| FR2514367A1 true FR2514367A1 (fr) | 1983-04-15 |
| FR2514367B1 FR2514367B1 (enExample) | 1984-07-20 |
Family
ID=9262861
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FR8118985A Granted FR2514367A1 (fr) | 1981-10-08 | 1981-10-08 | Procede pour la detection de germes pathogenes dans des fluides par filtration sur des immunoadsorbants, et application a la determination de la potabilite d'une eau |
Country Status (1)
| Country | Link |
|---|---|
| FR (1) | FR2514367A1 (enExample) |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1986002160A1 (en) * | 1984-09-26 | 1986-04-10 | Jan Peter Andersson | Device and method for trapping and analyzing particles |
| WO1987007726A1 (en) * | 1986-06-10 | 1987-12-17 | Jan Peter Andersson | Detection of organic particles, particularly viruses, with enrichment technique |
| WO1988000345A1 (en) * | 1985-03-25 | 1988-01-14 | Fassl Ab | Method and apparatus for qualitative and/or quantitative analysis of antigens, antibodies, mircroorganisms or other cells |
| EP0330688A4 (en) * | 1987-07-28 | 1991-05-15 | Biotechnology Australia Pty. Ltd. | Detection methods |
| US6004766A (en) * | 1987-07-28 | 1999-12-21 | Biotechnology Australia Pty Limited | Method for detecting low levels of microorganisms |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR1604982A (en) * | 1968-03-29 | 1972-06-26 | Active protein product - with polymeric carrier | |
| FR2382461A1 (fr) * | 1977-03-01 | 1978-09-29 | Abbott Lab | Antigene du virus de rubeole, purifie, son procede de fabrication et son application a la detection des anticorps du virus de rubeole |
| FR2403386A1 (fr) * | 1977-09-19 | 1979-04-13 | Hoffmann La Roche | Procede de preparation d'un reactif immunologique comprenant un polymere de latex |
-
1981
- 1981-10-08 FR FR8118985A patent/FR2514367A1/fr active Granted
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR1604982A (en) * | 1968-03-29 | 1972-06-26 | Active protein product - with polymeric carrier | |
| FR2382461A1 (fr) * | 1977-03-01 | 1978-09-29 | Abbott Lab | Antigene du virus de rubeole, purifie, son procede de fabrication et son application a la detection des anticorps du virus de rubeole |
| FR2403386A1 (fr) * | 1977-09-19 | 1979-04-13 | Hoffmann La Roche | Procede de preparation d'un reactif immunologique comprenant un polymere de latex |
Non-Patent Citations (2)
| Title |
|---|
| CA1974 * |
| CA1979 * |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1986002160A1 (en) * | 1984-09-26 | 1986-04-10 | Jan Peter Andersson | Device and method for trapping and analyzing particles |
| WO1988000345A1 (en) * | 1985-03-25 | 1988-01-14 | Fassl Ab | Method and apparatus for qualitative and/or quantitative analysis of antigens, antibodies, mircroorganisms or other cells |
| WO1987007726A1 (en) * | 1986-06-10 | 1987-12-17 | Jan Peter Andersson | Detection of organic particles, particularly viruses, with enrichment technique |
| EP0330688A4 (en) * | 1987-07-28 | 1991-05-15 | Biotechnology Australia Pty. Ltd. | Detection methods |
| US6004766A (en) * | 1987-07-28 | 1999-12-21 | Biotechnology Australia Pty Limited | Method for detecting low levels of microorganisms |
Also Published As
| Publication number | Publication date |
|---|---|
| FR2514367B1 (enExample) | 1984-07-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Craik et al. | Inactivation of Giardia muris cysts using medium-pressure ultraviolet radiation in filtered drinking water | |
| Alderete et al. | Identification and properties of Trichomonas vaginalis proteins involved in cytadherence | |
| EP0116793B1 (fr) | Procédé de détection immunobactériologique de germes pathogènes dans des milieux biologiques contaminés | |
| EP0057140A2 (fr) | Nouveau composé polypeptidique thiolé provenant d'un fragment de la toxine tétanique, son procédé d'obtention et ses applications | |
| Hofstad | Serological properties of lipopolysaccharide from oral strains of Bacteroides melaninogenicus | |
| FR2514367A1 (fr) | Procede pour la detection de germes pathogenes dans des fluides par filtration sur des immunoadsorbants, et application a la determination de la potabilite d'une eau | |
| EP0170302A1 (fr) | Procédé de dosage immunologique d'une substance dans un échantillon liquide au moyen d'anticorps anti-idiotypiques | |
| CN100501385C (zh) | 微量粒子的检测方法和装置 | |
| FR2541304A1 (fr) | Anticorps monoclonaux anti-legionella, procede d'obtention et application au diagnostic de pneumonies | |
| AU750326B2 (en) | Method for detecting (cryptosporidium parvum) oocysts | |
| Ibrahim et al. | Immunological relationships between Salmonella flagellins and between these and flagellins from other species of Enterobacteriaceae | |
| CN101979511A (zh) | 一种抗重金属锌的单克隆抗体 | |
| Jõgi et al. | The assessment of coli index with E. coli immunosensor in natural water | |
| Call et al. | Immunoassay for viable Cryptosporidium parvum oocysts in turbid environmental water samples | |
| Primrose et al. | The recovery of viruses from water: methods and applications | |
| Dissanayake et al. | Antibody determination in the diagnosis of Wuchereria bancrofti infection in man | |
| Adeyemo | Occurrence and Variations of Cryptosporidium and Giardia in Wastewater Treatment and Receiving River Basins | |
| JPH1118767A (ja) | 新規モノクローナル抗体およびその用途 | |
| Das | Cryptosporidium detection through antibody immobilization on a solid surface | |
| FR2700545A1 (fr) | Méthode de dosage des furocoumarines, et plus particulièrement du psoralène et de ses dérivés, composés et kits pour la mise en Óoeuvre de cette méthode. | |
| Bloch et al. | Use and interpretation of diagnostic immunologic laboratory tests | |
| EP0579720A1 (fr) | Anticorps anti-ace et leurs applications a la detection specifique et eventuellement a la numeration des enterobacteries entieres, par une methode immunochimique | |
| Odom et al. | [41] Immunoassay of sulfate-reducing bacteria in environmental samples | |
| FR2660197A1 (fr) | Anticorps purifies specifiquement diriges contre les lipopolysaccharides (lps) des bacteries gram negatif. | |
| JPS62500587A (ja) | モノクロ−ナル抗体およびその用途 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| ST | Notification of lapse |